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Abstract 
 
Single gene disorders are the most studied genetic diseases due to its simple inheritance 
pattern (recessive or dominant). Huntington’s disease (HD) is a single gene disorder which 
appears between the third and fifth decade of life. It is a progressive neurodegenerative 
disorder, which leads to 15-20 years of life expectancy after the first symptoms appear. Due 
to the late onset of the disease, an early diagnosis can be crucial, that is why an easy and 
cheap method of diagnosis is important. The disease is caused by the number of (CAG)n 
repeats in the huntingtin (Htt) gene; people with over 36 CAG repeats can develop the 
disorder. Previous molecular diagnosis had been developed, but were expensive or unsuitable 
for routine use. In this study, we developed a new, cheap and easy method to detect 
Huntington´s disease via PCR (polymerase chain reaction). To develop the new method, we 
tested specific primers in positive and negative control samples to verify the effectiveness. 
We tested the best concentrations of the reagents and conditions for the PCR. Due to the high 
concentration of the bases C and G, secondary structures were formed in the DNA chain in 
the amplicon, we used betaine for the disruption of this secondary structures. To measure the 
exact number of CAG repeats we made a semilogarithmic regression and used its equation. 
Results showed that the developed method was effective for the detection of the Huntington’s 
disease in positive and negative controls. With the developed method, we were able to 
perform the molecular diagnosis of an unknown individual with chances of developing the 
disease. Taken together, we have developed a new method of molecular diagnosis for the 
Huntington´s disease via PCR.  
Resumen 
 
Los trastornos monogénicos son las enfermedades genéticas más estudiadas debido a su 
simple modelo de herencia (dominante o recesivo). La enfermedad de Huntington (HD) es un 
trastorno monogénico que aparece entre la tercera y quinta década de vida. Es una enfermedad 
progresiva y neurodegenerativa, que lleva a 15-20 años de esperanza de vida después de que 
los primeros síntomas aparezcan. Debido a la tardía expresión de la enfermedad, un 
diagnóstico temprano es crucial, es por ello que un diagnóstico barato y sencillo es tan 
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importante. La enfermedad depende de las repeticiones de (CAG)n en el gen de la huntingtina 
(Htt); las personas con más de 36 copias de CAG pueden desarrollar la enfermedad. 
Anteriormente se han desarrollado diagnósticos moleculares pero eran caros o inadecuados 
para el uso rutinario. En este estudio hemos desarrollado nuevo, barato y fácil método para 
detectar la enfermedad de Huntington vía PCR (reacción en cadena de la polimerasa). Para 
desarrollar este nuevo método, hemos testado unos primers específicos en controles positivos 
y negativos para verificar la efectividad. Hemos testado las mejores concentraciones de los 
reactivos y las condiciones de la PCR. Debido a la gran concentración de bases C y G, se 
formaron estructuras secundarias en la cadena de ADN del amplicón, utilizamos betaína para 
deshacer esas estructuras secundarias. Para medir el número exacto de repeticiones de CAG, 
hicimos una regresión semilogarítmica y usamos la ecuación de esta regresión. Los resultados 
mostraron que el método desarrollado para detectar la enfermedad de Huntington era efectivo, 
tanto en controles positivos como negativos. Con el método desarrollado, fuimos capaces de 
hacer el diagnóstico molecular de un individuo con probabilidades de desarrollar la 
enfermedad. Resumiendo, hemos creado un método nuevo de diagnóstico molecular para 
detectar la enfermedad de Huntington vía PCR. 
 
1. Introduction  
 
Genetic diseases are caused by an abnormality or mutation in the genome. These diseases are 
not contagious, but can be transmitted through the generations. Among these kinds of 
diseases, the most studied genetic diseases are single gen disorders. This is due to its simple 
inheritance pattern (recessive or dominant) and the relative simple genetic etiology. The 
advances in understanding the mechanisms behind this diseases eases new diagnostic test, 
treatments or inventions to prevent or minimize the disease. It is really important to find new 
cheap and easy ways of diagnosis, because, an early diagnosis and detection of the disorder, 
can improve the treatment of the diseased (Genetic alliance, 2010).  
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1.1 Huntington disease 
 
Huntington’s disease (HD), also known as Huntington’s chorea, was discovered in 1972 by 
George Huntington. It is a progressive neurodegenerative disorder, which is hereditary and 
autosomal dominant. It affects the nervous system, mainly the regions of the brain in charge 
of the movement control. People with this condition usually have motor disturbance and 
abnormal body postures, changes in behaviour, emotion judgment and cognition. People with 
HD may also develop trouble speaking, feeding and swallowing (Roos, 2010). 
 
HD is a rare neurological and psychiatric condition; its frequency can vary among 
populations. It appears in all the ethnic groups and it affects 5 to 10 people in 100,000 in the 
Caucasian population. Different phenocopies have been described with lower prevalence than 
Huntington’s disease (Roos, 2010).   
 
The age of manifestation of Huntington’s disease can vary among the different individuals 
with the condition, but it usually appears during the third and fifth decade of life on men and 
women (Rosales-Reynoso & Barros-Nuñez, 2007). An earlier onset can also be seen, usually 
in people that have parents with this condition. The progressive increase of the disease leads 
to 15 to 20 years of life expectancy after the first symptoms appear, being pneumonia the first 
cause of death. (Vazquez-Cerdas et al., 2011).  
  
1.2 Genetics of  Huntington’s disease 
  
The gene affected in HD is located in the short arm of the 4th chromosome (4p16.3) (Roos, 
2010). This gene is responsible of coding the sequence for the Huntingtin protein (Htt) and 
has a CAG (cytosine, adenine, guanine) trinucleotide repeat; CAG is the codon responsible of 
the polyglutamine (or polyQ) site of the protein. The disorder is caused by a polymorphism on 
the number of repeats of the trinucleotide (CAG)n, and is classified as a polyQ disease, triplet 
expansion or protein conformation disease. The alteration in the number of the (CAG)n 
repeats causes a disorder in the configuration of the Huntingtin protein, leading to a 
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dysfunction of the protein and the already mentioned neurological and psychiatric disorders 
(Tasset et al.,2009). 
  
As mentioned before, the disorder is caused by the number of (CAG)n repeats. Normal alleles 
have between 9 and 36 repeats of the trinucleotide; people with these alleles will not develop 
the disorder and the number of trinucleotides will segregate without polymorphism in the 
99% of the cases. People with 29 to 34 repeats of the polyQ sequence will not develop the 
disorder during their lifetime, but the genotype can be unstable in the germinal cells, 
increasing the number of repeats in the next generation and increasing the chance of 
developing the disorder (Rosales-Reynoso & Barros-Nuñez, 2007). Higher instability has 
been seen in the spermatogenesis, rather than in the ovogenesis, this is the reason why is more 
common to develop the HD when the father has the mutated allele (Tasset et al., 2009). An 
incomplete penetrance is observed in people with 35 to 39 repeats of the CAG trinucleotide; 
this people will be meiotically unstable and can develop Huntington’s disease. People with 
more than 40 glutamines in the sequence will have complete penetrance and will always 
develop the disorder (Rosales-Reynoso & Barros-Nuñez, 2007).  
  
The diagnosis of Huntington’s disease is very unusual due to its late development, the 
diagnosis is made after the symptoms appear, familiar records and genetic analysis are the 
most commons ways of identification. Knowing the different ranges of the disease, 
polymerase chain reaction (PCR) has been used as a method for the diagnosis and 
identification of Huntington’s disease (www.ninds.nih.gov). Because people with mutated 
alleles don’t show different phenotypes, the molecular diagnosis is the only way of early 
detection of the disorder. Also, its late development, makes even more important the early 
detection of the condition, this is the reason why developing an easy and cheap method of 
molecular diagnosis to detect HD is so important. 
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1.3 Methods for HD molecular diagnosis 
 
Waner et al. (1993) developed an efective PCR assay to detect the disorder; previous PCR 
assays had been designed, but were difficult to perform and unsuitable for routine use. The 
main trouble for the amplification of the sequence is the high concentration of the bases 
guanine and cytosine (G and C) in the DNA. This G and C high concentration causes 
secondary structures in the DNA due to the binding of this two bases. To enhance the 
conditions of the PCR and disrupt the secondary structures, commercially available kits can 
be used to amplify CG rich sequences. The problem with these kits is that they are expensive; 
other additives like DMSO, betaine, formamide or glycerol, can be used as PCR enhancer, 
making lower costs and the final products being able to be visualized by ethidium bromide 
stained agarose gel electrophoresis (Bhagya et al., 2013).  Warner et al. (1993) used DMSO 
(dimethylsulphoxide) for the disruption of these secondary structures. DMSO changes the 
melting characteristics of the DNA and disrupts base paring; this can enhance the breakdown 
of secondary structures, but can also create nonspecific bands that can alter the interpretation 
of the results. Whereas, betaine is an isostabilicing agent that equalizes the contribution of CG 
and AT base paring to stabilize the DNA (Frackman et al., 1998). When DMSO is used, 
usually is mixed with betaine too, because DMSO denatures de DNA and betaine stabilizes 
the denatured DNA (Bhagya eta al., 2013). Furthermore, their method gave products from 80 
to 143 base pair (bp) for normal alleles (11 to 32 CAG repeats); and 173 or more base pairs 
for mutated alleles (42 CAG repeats), these PCR products are small and require a 6% 
denaturing polyacrylamide gel. 
2. Hypothesis	and	objectives 
 
Since Warner et al.’s (1993) method for detecting HD was old and with the actual information 
about HD, my hypothesis was that it would be possible to improve the method that they 
created, making it easier to detected diseased people with this condition. The main objective 
of this work was to make a new effective method to detect Huntington’s disease and the 
number of bp of each allele via PCR. Four mutated individuals were used to develop a 
method of detecting the disease, to check the effectiveness of the method, an individual with 
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chances of having HD (due to familiar record) was diagnosed with the created method. 
Different aims are going to be tested during the work, first, using betaine instead of DMSO to 
disrupt the secondary structures created by the high concentration of the bases G and C. It is 
expected better results in the disruption of the DNA using betaine, rather than DMSO, due to 
the isostabilizing effect of the betaine. It is also expected to appear nonspecific bands when no 
DMSO or betaine is used, because, as explained, the high concentration of CG can create 
secondary structures. Because of the length of the products of the PCR assay performed by 
Warner et al. (1993) were too short and required a denaturing polyacrylamide gel to 
determinate the absolute size, new primers had been designed for longer PCR products. 
Another aim was to prove that doing a semilogarithmic regression was posible to calculate the 
absolute size of the PCR products using only a 2-4% agarose gel, avoiding the use of DMSO 
and the denaturing polyacrylamide gel.  The last aim was to find the best concentrations of 
reagents and conditions for the PCR, that’s the reason why different reagent’s concentrations 
and temperatures in the PCR program were changed during the work. 
3. Materials and methods 
3.1 Individuals 
 
Seven anonymous individuals were used for the experiment. Four of the individuals had the 
mutated allele for Huntington’s disease (individuals 6, 7, 9 and 15); other two individuals had 
normal alleles and were used as control (individuals 3 and 4). The developed method was 
used to genotype an unknown individual (individual 11), with potential chances of developing 
the condition (due to its family record) and make a diagnosis. All mutated individual’s 
samples and individual 11 were bought from the Corriel Institute of Medical Research 
(www.corriel.org). The samples used as control were obtained from the laboratory’s DNA 
collection. Because individual 3 and 4 showed the same amplification length during the 
control, only individual 4 was used in in the PCRs with mutated alleles as a normal allele 
sample. The numbers of (CAG) repeats were known for the mutated alleles (individuals with 
Huntington’s disease), the data of the normal alleles (control samples) was unknown (Table 
1). The DNA concentrations of the other samples were, 6: 293.3 ng/μl; 7: 319.8 ng/μl; 9: 
306.8 ng/μl; 11: 303.2 ng/μl and 15: 295.5 ng/μl. 
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Table 1. Identification number of the anonymous individuals, the (CAG)n expansion of the mutated and control alleles of 
each individual (alleles with more than 40 (CAG) repeats are considered mutated alleles) and the expected length of the 
PCR amplification products for each allele. Individual 11 is going to be diagnosed to identify if it has the HD. 
Individual Number of (CAG) repeats  Expected length (in base 
pair) 
6  48  229  
7 55 & 15 250 & 130  
9 70 & 15 295 & 130 
15 66 & 16 283 & 133 
11 (diseased?) No data No data 
3  No data No data 
4 No data No data 
 
3.2 Primers  
 
Two control primers were used to determinate the viability of the DNA before using the 
specific Htt primers. The primer’s sequence used for the determination of the quality and 
viability of the DNA were, forward: 5’-GCA GCA GCT GGA CAA TGT CA-3’; reverse: 5’-
GCC CCA GCA GAG GAA GAA AA-3’. The PCR product was expected to have 429 base 
pair.The genomic sequences of the specific primers were, Htt-F (Foward): 5’-CGA CCC TGG 
AAA AGC TGA TG-3’; Htt-R (Reverse): 5’-CTG AGG AAG CTG AGG AGG C-3’. The 
PCR product sequence had 85 base pair + (CAG)n trinucleotide repeats (Fig 1). Products 
between 112 to 193 bp range were given for normal alleles (people with 9 to 36 repeats) and 
205 bp or bigger products for mutated alleles (>40 repeats, complete penetrance). People with 
incomplete penetrance (35 to 39 repeats) gave products in the 190 bp and 202 bp range. 
  
 
 CGACCCTGGAAAAGCTGAAGGCCTTCGAGTCCCTCAAGTCCTTCCAG(…)CAGCAACAGCC 
 
Htt-F         (CAG)n 
GCCACCGCCGCCGCCGCCGCCGCCGCCTCCTCAGCTTCCTCAG 
 
                                                                      Htt-R 
Fig. 1.  Sequence of amplification of the PCR analysis. Arrows indicate the binding side of the primers (Htt-F and Htt-R). 
(CAG)n repeats underlined, the number of repeats vary on each individual, giving different lengths on the PCR products. 
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3.3 PCR reagents concentrations, thermal cycler conditions and migration 
 
The different PCRs that were performed had equal concentrations of primers (specific or non-
specific), dNTPs, Tris-HCl (pH=8.3), KCl and Taq polymerase. All the PCRs were performed 
in a 50 μl volume, using 200 μM of each dNTPs (800 μM of total dNTPs), 200 μM of each 
primer, 10 mM of Tris-HCl (pH=8.3), 50 mM of KCl and 1.25 units of Taq polymerase. 
MgCl2, DNA, dimethylsulfoxide (DMSO) and betaine (Trimethylglycine) concentration vary 
depending the PCR assay.  
 
The thermo cycler conditions were equal in the first and third stage; the second step of the 
second stage varies in the different PCR assays (the first and third steps of the second stage 
were equal in all PCR assays). In the first stage, the thermal cycler was heated to 94ºC for 3 
min; them, the second stage had 35 cycles, the first step was at 94ºC for 1 min, the second step 
lasted 90 s in all PCR (but the temperature changed depending on the analysis) and the third 
step was at 72ºC for 150 s, after all the cycles were complete the final stage lasted 7 min at 
72ºC. 
 
All the polymerase chain reactions (PCR) were performed in an Applied Biosystems Veriti 
Thermal Cycler. To determinate the length of the products GeneRulerTM 1kb Plus DNA Ladder 
was used (Fig 2). The products of the PCR were resolved in a 2% agarose gel and stained 
with bromide ethidium. All the migrations were performed with 10 μl of each sample and 2,5 
μl of the DNA ladder.   
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Fig. 2. Length (in base pair, bp) of the GeneRulerTM 1kb plus DNA ladder in a 1% agarose gel. This DNA ladder was used in 
all the PCR assays of the work.  
 
 
 
3.4 Regression 
 
With the distance of migration and the log10 of the length (base pair), of the DNA ladder 
bands, two semilogarithmic regressions were made. The equation of the regressions were used 
to calculate and identify the length of the bands of the different individuals. One of the 
regressions was used to estimate the bp number of bands <200 bp and the other regression 
was used to calculate bands >200 bp. 
 
4. Results and Discussion 
  
4.1 Optimization of the PCR with control DNA of non-affected individuals 
 
4.1.1 Quality control of control DNA  
 
Before using the specific primers designed to detect the Huntington’s disease, control primers 
were used to test the viability of the control DNA. The main reason was to make sure that the 
control DNA had enough quality to be used as template for PCR reaction. If it wasn’t able to 
amplify, a different sample of control DNA should have been used instead. The other reason 
was to check that the designed primers to detect Huntington’s disease were able to amplify 
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DNA. After testing the viability of the DNA with the control primers, when using the specific 
primers if no DNA was amplified, it would be a mistake on the primers and not a problem on 
the DNA. 
  
The PCR was performed with the concentrations mentioned in the Materials and methods, 
with 3 mM of MgCl2 and without DMSO or betaine. The thermo cycler was heated to 94ºC 
for 3 min, them 35 cycles at 94ºC for 1 min, 56ºC for 90 s and 72ºC for 150 s, after all the 
cycles were complete the final stage lasted 7 min at 72ºC. A 2% agarose gel was used to 
resolve the products of the PCR (Fig 3). 
  
Two different control DNA samples were used, individuals 3 and 4 (Fig 3). The concentration 
of DNA of the samples was unknown. Different volumes (0.5 and 1 μl) of DNA were used for 
the PCR assay.   
 
 
 
Fig. 3. PCR analysis of the control DNA samples (individuals 3 and 4) with non-specific primers in a 2% agarose gel stained 
with bromide ethidium. Individual 3 (0.5 and 1 ul DNA; lanes 1 and 2), individual 4 (0.5 and 1ul DNA; lanes 3 and 4), the DNA 
ladder and the non-template control (NTC) . Arrow indicates the expected 429 bp band.  
  
0.5         1          0.5        1        μl 
DNA ladder              3                           4                NTC 
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The results showed that the control DNA was able to amplify with non-specific primers; also 
that 0.5 μl amplified better than 1μl. The expected 429 bp band appeared in all 4 lanes of the 
electrophoresis (Fig 3).  
 
4.1.1 Detection of the normal Htt alleles  
 
4.1.1.1 Optimization of the annealing temperature  
  
After testing that the control DNA was able to amplify, the specific primers for detecting 
Huntington’s disease were used with the control DNA. Only the control DNA was used 
(individuals 3 and 4), to make sure that the designed primers were able to amplify.  
  
The PCR was performed in a 50 μl volume, using the same concentrations as the ones used 
with the non-specific primers (but with the designed primers instead). After heating the 
thermocycler to 94ºC for 3 min, 35 cycles of 1min at 94ºC, 90 s at 55ºC or at 53ºC (two 
different temperatures were used in this stage) and 150 s at 72ºC; followed by 7 min at 72ºC. 
The PCR products were resolved in a 2% agarose (Fig 4). 
  
 
Fig. 4. PCR analysis of the control DNA samples (individuals 3 and 4) with the specific Htt primers, performed in a 2% 
agarose gel stained with bromide ethidium. Different temperatures were used, individual 3 at 55ºC (lane 1), individual 4 at 
55ºC (lane 2), individual 3 at 53ºC (lane 3), individual 4 at 53ºC (lane 4), DNA ladder and Non template control (NTC). Arrow 
shows the expected product size for a normal allele (>196 bp). 
  
55ºC               53ºC 
 DNA ladder    3          4         3        4      NTC  
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The bands that were expected to appear, were supposed to have between 112 and 196 base 
pairs. The results mainly showed bands between 500 and 700 base pairs, but a weak band of 
the expected size appeared in the samples that in the second stage of the 35 cycles were 
heated at 55ºC (Fig 4).  
  
Because the highest temperature used in the PCR (55ºC) showed a weak line, higher 
temperatures were used to determinate which temperature was better for the amplification of 
the DNA. Six different temperatures were used during the second stage of the 35 cycles. The 
temperatures used went from 55ºC to 60ºC for each individual of the control DNA. The PCR 
products were resolved in a 2% agarose gel (Fig 5). 
  
 
 
 
 
 
 
Fig. 5. PCR analysis of the control DNA (individuals 3 and 4) in a 2% agarose gel, stained with bromide ethidium. Different 
temperatures were used in the reaction, 55ºC (individuals 3 and 4, lanes 1 and 2), 56ºC (individuals 3 and 4, lanes 3 and 4) 
57ºC (individual 4, lane 7), 58ºC (individuals 3 and 4, lanes 10 and 11), 59ºC (individuals 3 and 4, lanes 13 and 14), 60ºC 
(individuals 3 and 4, lanes 16 and 17), the DNA ladder and the respectives non template controls (NTC) for each 
temperature. Arrow shows the expected product size for a normal allele (>196 bp). 
 
 
The products of the PCR increased with the temperature, especially in temperatures 57ºC and 
58ºC. In temperatures higher than 58ºC the products of the PCR decreased in quantity. 
 DNA     3     4      3     4    NTC   NTC   4   NTC   NTC    3     4    NTC   3     4     NTC    3     4   NTC 
         
55ºC       56ºC    55   56          57ºC              58ºC             59ºC            60ºC    
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Although the expected band size appeared (band between 112-196 base pair), non-specific 
bands between 300 and 700 base pair appeared again (Fig 5).  
 
As explained in the Introduction, due to the repetition of (CAG)n , a high concentration of the 
nucleotides cytosine (C) and (G) appear in the sequence. As expected, this high concentration 
of cytosine and guanine causes folds on the structure of the DNA chain, possibly due to the 
absence of DMSO or betaine in the PCR conditions. The secondary structures created by the 
linkage of C and G couldn’t migrate as desired in the agarose gel, creating the non-specific 
bands that appeared in Fig 5 and Fig 6. It could have been because of the high concentration 
of MgCl2. So one question to ask was, if due to the high concentration of MgCl2, the Taq 
polymerase was malfunctioning and hence creating more non-specific bands. Thus, another 
question to address was if the treatment with DMSO or betaine could improve the result by 
diminishing the secondary structures formation in the template DNA and, therefore enhance 
specific amplicon formation. 
 
4.1.1.2 Effects of the treatment with DMSO  
 
Like Warner et al. (1993) did, DMSO was used for the disruption of the secondary structures 
created by the bases C and G. Also MgCl2 concentration was lowered for the optimization of 
the polymerase, better results in the polymerase activity were expected when less 
concentration of MgCl2 was used. Four different amplifications, with different concentrations 
of the reagents, were performed with the individuals 3 and 4.    
 
The concentrations of the reagents for the PCR were the ones mentioned in the Materials and 
methods section. The assays were performed with 3 mM of MgCl2, 3 mM of MgCl2 and 10% 
DMSO, 1.5 mM MgCl2 and with 1.5 mM MgCl2 and 10% DMSO. The temperature used in 
the second step of the second stage was 58ºC.  
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Fig. 6. PCR analysis of the control DNA samples (individuals 3 and 4), with different concentrations in the master mix due to 
the use of DMSO and lower concentration of MgCl2. The PCR products were resolved in a 2% agarose gel stained with 
bromide ethidium. Different concentration of the reagents used 3 mM MgCl2 (lanes 1-3), 3 mM MgCl2 and 10% DMSO (lanes 
4-6), 1.5 mM MgCl2 (lanes 7-9), 1.5 mM MgCl2, 10% DMSO (lanes 10-12), DNA ladder and non template control (NTC). 
 
 
The results showed that lower concentrations of MgCl2 (1.5 mM) improved the results of the 
PCR reaction, creating less non-specific bands and concentrating same size amplicons (Fig 6). 
Unlike Warner et al. (1993), DMSO wasn’t effective for the disruption of the secondary 
structures created by the high concentration of C and G. This might be due to the effect of 
DMSO in the DNA chain. DMSO can cause mismatches in the primer-binding step and can 
affect the Taq polymerase binding (Hardjasa et al., 2010), this can hider the PCR reaction and 
alter the results. In lanes 4 and 10 can be seen that Individual 3’s DNA didn’t amplify when 
DMSO was used, this could be because of a mismatching on the primers with the DNA 
sequence, making impossible the identification and measurement of the length of the expected 
bands (Fig 6).  
 
4.1.1.3 The effects of the treatment with betaine  
 
Betaine was used instead of DMSO for the disruption of the DNA secondary structures. The 
concentrations and conditions of the PCR were the ones described in the Material and 
3 mM MgCl2         3 mM MgCl2            1.5 mM MgCl2        1.5 mM MgCl2 
     10% DMSO                         10% DMSO 
DNA        3       4    NTC    3       4    NTC    3       4    NTC    3      4     NTC 
ladder  
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methods section with 1.3 M of betaine, 1.5 mM of MgCl2 and 58ºC in the second step of the 
second stage. Since individual 3’s DNA wasn’t able to amplify in presence of DMSO and 
previous PCR products showed same band size in individual 3 and 4’s expected products, 
only individual 4’s DNA was used in this assay. 
 
 
Fig. 7. PCR analysis of the Individual 4 with Htt primers, performed in a 2% agarose gel and stained with bromide ethidium. 
The PCR was made without betaine (lane 1), with betaine (lane 2), DNA ladder and non template control (NTC). Arrow 
shows the expected band size (>196 bp). 
 
 
When betaine was used in the PCR reaction, the disruption of the secondary structures of the 
DNA was successful. Unlike DMSO, the results showed that betaine was more effective in 
the secondary structures disruption. When no betaine was used in the PCR nonspecific bands 
appeared in the PCR products (Fig 7). Also, betaine enhanced the PCR reaction better than 
DMSO, due to its isostabilizing activity on the DNA, whereas DMSO denatures the DNA 
sequence creating mismatches and hindering the PCR reaction. As Henke et al. (1997) and 
Frackman et al. (1998) showed in their respective works, betaine is a more effective PCR 
enhancer in presence of high concentrations of G and C DNA sequences.  
 
 betaine     betaine 
    (-)            (+) 
DNA ladder                         4                NTC 
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4.2 Analysis of the control DNA of affected individuals and test DNA  
 
4.2.1 Quality control and minimum concentration of DNA for PCR 
 
Before using the specific primers (Htt primers) with the mutated DNA, the nonspecific 
primers were used to amplify the mutated DNA, in order to check for the quality of the 
mutated DNA. Also, serial dilutions of the mutated DNA were performed to determinate the 
best concentration of the DNA, for the later amplification with the Htt primers.  
 
 The dilutions performed were 1, 1/2, 1/4, 1/8, 1/16, 1/32, 1/64, 1/128 and 1/256 for all the 
mutated samples. The PCR was performed with the concentrations and conditions described 
in the Material and methods, with 1.5 mM of MgCl2 and 58ºC on the second step of the 
second stage of the PCR. 
 
 
6 7 
7                             9                                  NTC 
    1        1/2       1/4      1/8     1/16    1/32     1/64   1/128  1/256      1        1/2      1/4       1/8     1/16 
 
  1/32     1/64   1/128   1/256     1        1/2      1/4      1/8      1/16    1/32    1/64     1/128  1/256   
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Fig. 8. PCR analysis of the mutated DNA samples individuals 6 (lanes 1-9), 7 (lanes 10-18), 9 (lanes 19-27), 11 (lanes 28-
36) 15 (lanes 37-46), DNA ladder and non template control (NTC); with non-specific primers in a 2% agarose gel, stained 
with bromide ethidium. Above each lane the respective dilution factor 1, 1/2, 1/4, 1/8, 1/16, 1/32, 1/64, 1/128 and 1/256. 
Arrow indicates the expected 429 bp bands.  
 
 
All mutated DNA samples were able to amplify in presence of the non-specific primers (Fig 
8). In all the individuals, the selected dilution for the amplification of the DNA with Htt 
primers was 1/16 of the original concentration. The concentrations of DNA for each 
individual  (1/16 dilution) were, for individual individual 6: 18.33 ng/μl; individual 7: 19.99 
ng/μl; individual 9: 19,17; individual 11: 18.95 ng/μl and 15: 18.47 ng/μl. 
11 15 
15 
     1        1/2       1/4       1/8      1/16     1/32    1/64    1/128   1/256      1        1/2       1/4       1/8     1/16 
 
 1/32               1/64              1/128             1/256 
NTC 
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4.2.2 Detection of the affected Htt alleles with the optimized methodology  
Finally, to calculate the number of CAG repeats, the mutated DNA was amplified with the Htt 
primers and a semilogarithmic regression was made. Mutated DNA, was expected to have 
>196 bp (36 CAG repeats), bands smaller than <196 bp would indicate a normal allele; but, 
bands between 190 and 202 bp would indicate an incomplete penetrance, which can be 
meiotically unstable and develop Huntington’s disease. 
 
The PCR was made with the concentrations and conditions mentioned in the Materials and 
methods. 1.3 M of betaine was used for the disruption of the secondary structures and 1.5 mM 
of MgCl2 for the optimal functioning of the Htt primers. The second step of the second stage 
of the PCR was performed at 58ºC. 
 
 
Fig. 9. PCR analysis of the mutated DNA samples (individuals 6, 7, 9 and 15; lanes 1, 2, 3 and 4 respectively), normal allele 
(individual 4; lane 5), DNA ladder and non template control (NTC); performed in a 2% agarose gel and stained with bromide 
ethidium. Bands over 200 bp indicate more than 38 CAG repeats in the DNA sequence. 
 
 
As expected, the betaine used in the PCR reaction made the electrophoresis viable; the 
respective bands sizes for each individual were observed (Fig 9). The DNA ladder and the 
200 bp 
 
     DNA    6     7     9   15    4   NTC 
      ladder  
               Affected individuals 
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bands distance were used to create a semilogarithmic regression and estimate the CAG 
repeats in each individual.The distance of the DNA ladder bands and the log10 of the length of 
those bands (in bp) were used to make the two semilogarithmic regression (Fig 10). The 
already known band size of each individual was used to compare with the estimated size 
(Table 2). 
 
 
Fig. 10. The semilogarithmic regression and its equations, used estimate the number of bp of the different individuals. The 
regression on the left was used to calculate bands with >200 bp. The regression on the right was used to calculate bands 
with <200 bp. 
 
Table 2. The expected length and the calculated length (in bp) of the mutated individuals. The length of each band was 
calculated with the equations of the semilogarithmic regression in Fig 10.  
Individuals Expected length (bp) Calculated length (bp) 
6 229 230.83 
7 250 & 130 293.02 & 127.93 
9 295 & 130 293.02 & 127.93 
15 283 & 133 283. 20 & 133.97 
 
Using the equations calculated in Fig 10 the length of each band was estimated. The estimated 
length size of each band was almost exact (±1.398 bp). Besides individual 7’s mutated band 
y	=	0,0074x	+	0,8907R²	=	0,99924
2,252,32,35
2,42,452,5
2,552,62,65
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y	=	0,01x	+	0,347R²	=	0,99116
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(>196 bp) couldn’t be measured correctly due to a wrong migration (Table 2). It was proved 
that the method was effective to distinguish normal and mutated alleles (Fig 9), and that it 
was posible to measure the bp number of those alleles (Fig 10). Using the equations of Fig 10, 
individual 11’s bp number was going to be measured to identify if it was affected by 
Huntington’s disease.  
 
4.3 Molecular diagnosis of individual 11 
 
Because the developed method was effective, individual 11 was diagnosed to check if he had 
HD and to measure the number of bp of its alleles. The reason why individual 11 is tested 
with this method, is because, as explained in the Materials and method section, this individual 
could be affected by Huntington’s disease due to familiar record. 
 
Fig 9 was edited for the better understanding of the results, indeed Fig 9 and Fig 11 are the 
same gel. The reason why it has to be the same gel is to apply the equations of Fig 10, its 
regression is specific for each gel, because the migrated distance vary each time the 
electrophoresis is performed. This means that a new regression has to be done each time a test 
is performed.   
 
 
Fig. 11. PCR analysis of the mutated DNA samples (individuals 6, 7, 9 and 15; lanes 1, 2, 3 and 5 respectively), normal 
allele (individual 4; lane 6), test DNA (individual 11; lane 4), DNA ladder and non template control (NTC); performed in a 2% 
agarose gel and stained with bromide ethidium. The results showed that individual 11 was affected by HD. Bands over 200 
bp indicate more than 38 CAG repeats in the DNA sequence. 
 
      DNA    6    7    9    11   15    4   NTC 
        ladder  
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The results showed that individual 11 was affected by Huntington’s disease, because its band 
was over 200 bp (Fig 11). For the exact measurement of the number of bp, the equations of 
the Fig 10 were used, the calculations showed that he had 219,33 bp which is 45 (CAG)n 
repeats, resulting in a affected individual of the HD. 
 
4.4 Relevant outcomes 
 
The molecular diagnosis developed by Warner et al. (1993) was effective but required the use 
of DMSO, which can cause problems in the binding sides of the primers, hindering the 
amplification of the products in the PCR. Also, a denaturing polyacrylamide gel is required 
for the estimation of the length of the bands. With the method developed in this work the 
estimation of the length of the bands only require a 2% agarose gel. It has to be said that some 
complications may appear, for example a wrong migration can cause an erroneous estimation 
of the length of the bands (individual 7, Table 2). Also an individual with two alleles, with 
difference of ±	1-2 CAG repeats might not be distinguish if it is heterozygote or homozygote. 
Diluting the DNA and creating thinner band sizes can overcome these problems. The method 
developed in this work can be an easy and cheap way to find individuals with Huntington’s 
disease. 
5. Conclusion 
1. Regarding to the PCR concentrations and conditions, high concentration of MgCl2 create 
more nonspecific bands due to the different sizes of the amplicons, also, 58ºC was the optimal 
temperature for the amplification. 
 
2. When no betaine or DMSO was used, nonspecific bands appear because of the high 
concentration of the bases C and G.  
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3. Betaine works better than DMSO, in the disruption of the secondary structures formed by 
the high concentration of the bases C and G. 
 
4. The developed method works and it´s suitable for molecular diagnosis of the Huntington´s 
disease. A rough observation of the results is enough to predict the outcome of the 
individuals, since individuals with over 200 bp have a mutated allele.  
 
5. In order to perform an accurate diagnosis, creating a semilogarithmic regression the exact 
number of bp can be estimated, knowing the size of the amplicon, the exact number of CAG 
repeats can be estimated.  
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